Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0562 USD | 0.00% | -10.08% | +51.89% |
May. 02 | North American Morning Briefing : Stock Futures -2- | DJ |
Apr. 25 | North American Morning Briefing : More Tech -2- | DJ |
Financials (USD)
Sales 2021 | - | Sales 2022 | - | Capitalization | 8.59M |
---|---|---|---|---|---|
Net income 2021 | -17M | Net income 2022 | -19M | EV / Sales 2021 | - |
Net cash position 2021 | 23.78M | Net cash position 2022 | 6.72M | EV / Sales 2022 | - |
P/E ratio 2021 |
-1.66
x | P/E ratio 2022 |
-0.43
x | Employees | 18 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 84.97% |
Latest transcript on Bellerophon Therapeutics, Inc.
1 week | -10.08% | ||
Current month | +2.00% | ||
1 month | -6.33% | ||
3 months | -12.19% | ||
6 months | +56.11% | ||
Current year | +51.89% |
Managers | Title | Age | Since |
---|---|---|---|
Craig Jalbert
CEO | Chief Executive Officer | 63 | - |
Martin Dekker
CTO | Chief Tech/Sci/R&D Officer | 51 | 15-01-28 |
Edwin L. Parsley
CTO | Chief Tech/Sci/R&D Officer | 63 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Naseem Amin
CHM | Chairman | 62 | 15-06-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 0.0562 | 0.00% | 506 |
24-05-09 | 0.0562 | +0.36% | 8,382 |
24-05-07 | 0.056 | 0.00% | 19,616 |
24-05-06 | 0.056 | -10.40% | 38,997 |
24-05-02 | 0.0625 | +21.83% | 10,622 |
Delayed Quote OTC Markets, May 10, 2024 at 09:30 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+51.89% | 687K | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- BLPH Stock